• Romidepsin (FK228, depsipeptide) in Cell Assays

  2026-09-18

  This scenario-driven guide explains how Romidepsin (FK228, depsipeptide), SKU A8173, can improve the design and interpretation of cell viability, proliferation, and cytotoxicity assays. It connects HDAC1/2 selectivity, solvent handling, exposure planning, and orthogonal validation to practical laboratory decisions.

• Dual-Action Inhibitors Reprogram p38α Dephosphorylation

  2026-09-18

  The reference preprint shows that selected p38α MAP kinase inhibitors can do more than suppress catalytic activity: they can stabilize an activation-loop conformation that accelerates dephosphorylation by WIP1. Biochemical kinetics and X-ray structures connect phospho-threonine accessibility with kinase inactivation, offering a mechanistic framework for designing more durable and selective kinase inhibitors.

• Tropisetron Hydrochloride: Assay Design Guide

  2026-09-17

  Tropisetron Hydrochloride is more than a receptor pharmacology tool: it can also expose important variables in renal transporter assays. This guide connects 5-HT3 receptor antagonism, α7-nicotinic receptor signaling, and OCT2/MATE1 assay design to improve interpretation of neuroscience and drug-interaction experiments.

• Cefazedone (Refosporen): From PBP Biology to Translation

  2026-09-17

  Cefazedone, also known as Refosporen, is more than a broad-spectrum cephalosporin control: it is a useful translational anchor for connecting penicillin-binding protein biology, β-lactamase-aware antibacterial testing, comparator interpretation, and exposure-driven decision-making. This article outlines how researchers can use Cefazedone to build more informative antibacterial workflows without overextending historical data.

• Sulfo-NHS-SS-Biotin for Reliable Cell Assays

  2026-09-16

  This scenario-based guide explains how Sulfo-NHS-SS-Biotin, SKU A8005, can clarify cell-surface protein changes that complicate viability, proliferation, and cytotoxicity studies. It covers reagent compatibility, fresh-preparation requirements, reversible affinity capture, interpretation limits, and practical vendor-selection criteria.

• Cyanidin Chloride: Redox-to-Barrier Translation

  2026-09-16

  A mechanistic and strategic guide to using Cyanidin Chloride in oxidative stress, inflammatory skin, and barrier-function research while preserving chemical-identity and translational boundaries.

• Camptothecin as a Lens on Genome Adaptation

  2026-09-15

  Camptothecin is a topoisomerase I inhibitor and DNA damage inducer that connects acute cancer-cell stress with emerging research on adaptive mutagenesis. This article explains how to use its signaling and chemical profile to design assays that distinguish DNA damage, repair-state effects, autophagy, senescence, and long-term evolutionary change.

• Mitomycin C: From DNA Lesions to Translation

  2026-09-15

  A thought-leadership guide to using Mitomycin C as a mechanistically defined DNA-damage perturbation in cancer research. It connects adduct-driven replication stress, p53-aware apoptosis signaling research, ERCC1 biology, TRAIL sensitization, and translational experimental design.

• Triiodothyronine T3 for Signaling and Cell Assays

  2026-09-14

  Triiodothyronine (T3) provides a controlled way to study thyroid hormone receptor activation, metabolic state, and transcriptional responses in cellular models. This guide combines practical T3 assay design with lessons from a recent oligodendrocyte base-editing study, while clearly separating validated findings from exploratory cross-domain applications.

• LY294002 Workflows for PI3K Signaling Studies

  2026-09-14

  Build more interpretable PI3K/Akt/mTOR experiments with LY294002 by combining dose-response design, timed pathway readouts, and macrophage-focused controls. The workflow connects cancer-cell assays with the TLR4-linked macrophage polarization findings reported in colitis-associated colorectal cancer research.

• Isoprinosine and HSV-1: From Immunity to Mechanism

  2026-09-13

  A translational framework for positioning Isoprinosine in herpesvirus research, connecting inosine pranobex immunomodulation with new evidence that CLCC1 supports HSV-1 nuclear egress while preserving a clear boundary between established findings and testable hypotheses.

• Cell Counting Kit-8 (CCK-8): Reliable Cell Data

  2026-09-12

  Learn how Cell Counting Kit-8 (CCK-8), SKU K1018, addresses common problems in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay principles, controls, protocol optimization, interpretation, and practical product selection.

• HIV-1 Nuclear Pore Remodeling Licenses Infection

  2026-09-11

  Mesner et al. identify nuclear import at the nuclear pore complex as a major barrier to HIV-1 infection of resting CD4+ T cells. Their work shows that cell–cell spread activates CD4–LCK–CDK1 signalling, remodels nucleoporins, and licenses infection without requiring conventional cell-cycle entry.

• iMSC Exosomes Reprogram Macrophages in IDD

  2026-09-11

  This study identifies a reciprocal inflammatory circuit between senescent nucleus pulposus cells and macrophages in intervertebral disc degeneration. It further shows that exosomes from human iPSC-derived mesenchymal stem cells deliver miR-100-5p, suppress mTORC1-linked glycolytic programming, redirect macrophages toward an anti-inflammatory state, and mitigate degeneration in a rat model.

• Neurotensin: Designing Better GPCR Assays

  2026-09-10

  Neurotensin is a precise tool for connecting NTR1 activation with GPCR trafficking and miRNA regulation in gastrointestinal cells. This assay-design guide shows how to combine causal controls with interference-aware fluorescence analysis for more reproducible results.

654 records 1/44 page Next 12345 下5页 Last page